Carnitine transport and fatty acid oxidation

Area of Science:

• Biochemistry
• Genetics
• Metabolic Disorders

Background:

• Carnitine facilitates fatty acid transfer into mitochondria for energy production.
• Cellular carnitine levels are maintained by the OCTN2 transporter, crucial for preventing carnitine loss.
• Defects in OCTN2 cause primary carnitine deficiency, impacting cellular energy metabolism.

Purpose of the Study:

• To elucidate the role of OCTN2 in carnitine transport and its implications in primary carnitine deficiency.
• To describe the clinical manifestations, diagnosis, and management of primary carnitine deficiency.
• To highlight the genetic basis and diagnostic approaches for this metabolic disorder.

Main Methods:

• Review of existing literature on carnitine metabolism and OCTN2 function.
• Analysis of clinical presentations and diagnostic criteria for primary carnitine deficiency.
• Discussion of genetic testing (SLC22A5 gene sequencing) and carnitine uptake assays.

Main Results:

• Primary carnitine deficiency results from OCTN2 transporter defects, causing low serum and intracellular carnitine.
• Clinical symptoms range from hypoglycemia and hepatic issues in infants to myopathy and cardiac arrhythmias in adults.
• Newborn screening for carnitine levels and fibroblast uptake assays aid in diagnosis, with oral carnitine as an effective treatment.

Conclusions:

• Primary carnitine deficiency is a treatable genetic disorder affecting fatty acid oxidation.
• Accurate diagnosis through clinical suspicion, newborn screening, and genetic testing is vital.
• Understanding OCTN2 function is key to managing carnitine homeostasis and preventing severe health consequences.